Maybe when it enters some of the indexes, say top 300, All Ords etc etc. not sure what the parameters are these days. when it happens Portfolio type fund managers have to buy it, some probably don't know who they are buying or what they do.
- Forums
- ASX - By Stock
- New Canary Report - Price update to $1.10
Maybe when it enters some of the indexes, say top 300, All Ords...
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
-0.035(5.43%) |
Mkt cap ! $133.6M |
Open | High | Low | Value | Volume |
64.0¢ | 65.0¢ | 61.0¢ | $304.0K | 488.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 61.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.5¢ | 4100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 0.610 |
5 | 27011 | 0.605 |
12 | 120025 | 0.600 |
1 | 8386 | 0.595 |
2 | 15364 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.615 | 4100 | 1 |
0.620 | 3644 | 1 |
0.625 | 22882 | 2 |
0.630 | 45087 | 3 |
0.640 | 4500 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online